Hong Kong: Transition to UBI and updated Companies Registry forms

In brief

The Companies Registry has announced the adoption of an Unique Business Identifier (UBI) for all entities under the administration of the Registrar of Companies ("Registrar") on 27 December 2023 and revised 117 specified forms to take effect from the same date.


Contents

UBI enables legal entities to be distinctly identified in various transactions and regulatory interactions. The Business Registration Number (BRN) (i.e., the first eight digits of the Business Registration Certificate number), assigned by the Business Registration Office of the Inland Revenue Department, will be adopted as the UBI of all companies and entities in Hong Kong.

For companies or entities which do not have a BRN, such as companies exempted from registration under the Business Registration Ordinance (Cap. 310), a dummy BRN converted from the previous company number or company registration number of the companies or entities in the Registry's records will be adopted as the UBI.

The UBI will be implemented by the Companies Registry in two phases: the first phase for limited partnership funds took effect from 1 November 2021 and the second phase, covering limited companies and all other entities, will be implemented simultaneously with the launch of the Companies Registry's revamped Integrated Companies Registry Information System on 27 December 2023.

Key features of Phase 2 of UBI on companies and entities include the following:

  • BRN will be adopted as the “No.” on the Certificate of Incorporation, Certificate of Registration, or Certificate of Change of Name issued by the Companies Registry
  • BRN, instead of the existing company registration number, will have to be quoted on specified forms and documents delivered to the Companies Registry
  • BRN will be the key number for searching and identifying a company or entity under different services of the Companies Registry

To facilitate the implementation of Phase 2 of UBI, the Registrar has revised 117 specified forms with effect from 27 December 2023, for the following major purposes:

  • Adopting the BRN as the UBI of a company or entity
  • A new structured format for reporting addresses
  • A revised format for reporting details of shareholders

There will be a transitional period of six months where both old and new forms will be accepted, except as follows:

  • Forms NNC1 NNC1G, NNC5 and NN1 have a shorter transitional period of four weeks i.e. only new forms will be accepted from 25 January 2024 onwards
  • Forms for open-ended funds do not have any transitional period

 

                                                                                                * * * * *

For further information and to discuss what this might mean for your company and whether any actions have to be taken, please get in touch with any of us under the "Contact Information" or your usual Baker McKenzie contact.

 

Contact Information
Liza Murray
Partner at BakerMcKenzie
Hong Kong
liza.murray@bakermckenzie.com
Jannie Mak
Senior Manager at BakerMcKenzie
Hong Kong
jannie.mak@bakermckenzie.com

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.